biotech

  • Creating life through generative design Crunch Network

    Creating life through generative design

    We have been shaping the organisms that live around us for a long time. Take as an example the changes we forced on wolves to become our best friends. Traditionally, we accomplished it by selecting organisms with special traits (“Let’s keep that wolf, it doesn’t bite as much”). In the last 20 years we have gone further by modifying the genetic programming of… Read More

  • Bio

    13 women leading the life sciences movement in Silicon Valley

    Breakthroughs in genetic engineering, 3D printing, cloud-based science experiments, A.I. and machine learning technology have created a weird and cool new kind of cutting-edge biotech that goes beyond pharma into what just a few decades ago seemed like magical thinking. And women are leading the charge in this brave new world, especially in Silicon Valley. While there are plenty of women… Read More

  • Bio
    Rythm raises $11M to pursue sleep-improving neurotechnology

    Rythm raises $11M to pursue sleep-improving neurotechnology

    French startup Rythm, which makes a tech-infused headset it claims improves sleep quality, announced Tuesday that it’s raised over $11 million from private investors and public grants. Read More

  • What life science investors got right in this most recent boom

    What life science investors got right in this most recent boom

    It’s long been the case that life sciences investors don’t get the attention that their more traditional tech counterparts do. They’re underrepresented on lists of top investors in venture capital. They’re also remarkably underfunded, according to institutional investors (or limited partners) who back venture firms. It’s the “life sciences guys who are smart… Read More

  • Bio
    Microsoft co-founder Paul Allen pledges $100 million toward cutting-edge biotech research

    Microsoft co-founder Paul Allen pledges $100 million toward cutting-edge biotech research

    Investor, entrepreneur, billionaire and Bill Gates’ other half in the founding of Microsoft Paul Allen has announced a $100 million investment in the Paul G. Allen Frontiers Group, a fund focusing on the future of biotech research. Allen, who is worth about $15.3 billion, announced the investment today at the National Academy of Sciences in Washington, D.C. The purpose of this… Read More

  • Bio
    YC-backed Perlstein Lab continues their rare disease drug discovery

    YC-backed Perlstein Lab continues their rare disease drug discovery

    Perlstein Lab, or PLab as it is also known, continues to hone its automated drug discovery platform and presents its latest iteration Wednesday March 23rd at Y Combinator Demo Day. The platform they created helps the bio startup focus on finding cures for rare diseases rather than common ones. This novel approach is different from most Big Pharma labs and is thus one of their differentiators. Read More

  • Bio
    Life Sciences Marketplace Quartzy Raises $17 Million To Build Up The Supply Side

    Life Sciences Marketplace Quartzy Raises $17 Million To Build Up The Supply Side

    Quartzy, a lab supplies marketplace, announced it has closed a $17 million round in Series B financing to help the startup build up the supply of lab equipment offered to customers. The startup launched out of Y Combinator four years back and has since partnered with several academic institutions, including Stanford to offer an alternative marketplace for pricier lab supplies. Quartzy does so… Read More

  • Here Come The Dannies Crunch Network

    Here Come The Dannies

    Take a quick look, a sneak peek, into our not-so-distant future, courtesy of the great science-fiction writer Peter Watts(1), who writes in Aeon magazine: “You already know that we can run machines with our brainwaves. That’s been old news for almost a decade… But we’ve moved beyond merely thinking orders at machinery. Now we’re using that machinery to wire… Read More